Trials24-Logo_v1

Trials24 at MNG Lecture Events with Speech “New Treatment Modalities: Regulatory Implications and Patient Recruitment”

Trials24's CEO, Dr. Tobias Kruse, and Dr. Ulrich Granzer collaborated at an MNG Lecture Event, discussing "New Treatment Modalities: Regulatory Implications and Patient Recruitment," covering challenges in patient recruitment and approaches like decentralized and online patient recruitment.

 

On March 29th, 2023, Dr. Tobias Kruse, CEO of Trials24, and Dr. Ulrich Granzer, CEO of Granzer Regulatory Consulting & Services, participated in an MNG Lecture Event dedicated to the topic “Biotech in Germany – Opportunities in Crisis” in Research Center of Bayer AG Wuppertal.

 

In this collaborative lecture, “New Treatment Modalities: Regulatory Implications and Patient Recruitment,” Dr. Kruse covered the following topics:

  • The challenge of patient recruitment
  • Introduction to decentralized patient recruitment
  • Online patient recruitment approach for rare diseases

 

If you have any questions about this event or need to shorten your patient recruitment timeline, please get in touch with us here.

 

Image from: Trials24 Marketing Department